AIDS Alert Archives – October 1, 2005
October 1, 2005
View Issues
-
ADAP funding and Ryan White Act renewal is delayed by hurricane
The AIDS Drug Assistance Program (ADAP) already was in trouble financially, particularly in Southeastern states, when Hurricane Katrina wreaked devastation in Louisiana, Mississippi, and Alabama, making matters worse. -
HIV substance abusers encouraged to use new case management program
A strengths-based case management program for HIV-positive patients who are active substance abusers appears to have some success in directing such patients to HIV care and treatment, according to recent research. -
Adherence Strategies: Researchers study use of the 'MATI' for improving AIDS drug adherence
Investigators have found that an adherence tool that addresses multiple factors contributing to adherence difficulties can assist with better adherence. -
AIDS Alert Q&A: Italian researcher continues to focus on hydroxyurea treatment for HIV
Editor's note: In this Q&A interview, Franco Lori, MD, scientific director of the Research Institute for Genetic and Human Therapy (RIGHT) of Washington, DC, and Pavia, Italy, discusses the recent positive outcomes of his research for an optimal hydroxyurea treatment for HIV and what he calls the "Virostatic" approach to HIV treatment. -
New streamlined risk assessment for HIV clinicians
The public health community noted improvements in sexual risk behaviors among HIV positive people in the 1990's, but the positive gains have been lost in the 21st century as unsafe sexual behaviors have increased among some HIV positive populations. -
FDA Notifications
The Food and Drug Administration (FDA), September 7, 2005, announced the tentative approval of zidovudine oral solution manufactured by Aurobindo Pharma LTD.